skip to content
Home

Cambridge Immunology Network

 

CIN News Subscribe to News

Read more at: Clare Bryant wins Alzheimer's Research UK's Interdisciplinary Research Grants
Clare Bryant wins Alzheimer's Research UK's Interdisciplinary Research Grants

Clare Bryant wins Alzheimer's Research UK's Interdisciplinary Research Grants

2 October 2014

Professor Clare Bryant has been awarded one of Alzheimer's Research UK's first ever Interdisciplinary Research Grants, bringing her expertise in immunology to a new collaboration in dementia research.

Read more at: Andres Floto has been appointed as Professor of Respiratory Biology

Andres Floto has been appointed as Professor of Respiratory Biology

1 October 2014

Andres Floto has been appointed as Professor of Respiratory Biology

Read more at: The Cambridge Immunology Network has a new chair

The Cambridge Immunology Network has a new chair

26 September 2014

Arthur Kaser and Clare Bryant are the new chair and deputy chair for the Cambridge Immunology Network

Read more at: The Cambridge Institute of Therapeutic Immunology and Infectious Disease is coming

The Cambridge Institute of Therapeutic Immunology and Infectious Disease is coming

16 July 2014

Cambridge Institute of Therapeutic Immunology and Infectious Disease receives £25 million of government funding

Read more at: Inactivation of phosphoinositide-3-OH kinase δ as a possible cancer treatment in Nature this week
Inactivation of phosphoinositide-3-OH kinase δ as a possible cancer treatment in Nature this week

Inactivation of phosphoinositide-3-OH kinase δ as a possible cancer treatment in Nature this week

12 June 2014

Phosphoinositide-3-OH kinase δ restrains the anti-tumour immune response by promoting the action of suppressive immune cells

Read more at: Alemtuzumab is approved by NICE for treatment of MS
Alemtuzumab is approved by NICE for treatment of MS

Alemtuzumab is approved by NICE for treatment of MS

1 June 2014

A drug based on decades of research at the University of Cambridge has today been approved by the National Institute for Health and Care Excellence (NICE) for use in people with relapsing-remitting multiple sclerosis. Clinical trials have shown that Alemtuzumab, marketed under the name Lemtrada, reduces disease activity, limits the accumulation of further disability over time and may even allow some existing damage to recover.

Read more at: Immunology PhD and Postdoc Day
Immunology PhD and Postdoc Day

Immunology PhD and Postdoc Day

15 April 2014

29 May 2014, Sainsbury Centre, Bateman Street, all day scientific presentations and posters from Cambridge Immunology PhD students and postdocs.

Read more at: Peanut Allergy Trial
Peanut Allergy Trial

Peanut Allergy Trial

30 January 2014

A report on a randomised trial using to relieve peanut allergies in children was published in the Lancet today and received extensive publicity

Read more at: Ken Smith wins Lupus Research Institute Distinguished Innovator Award

Ken Smith wins Lupus Research Institute Distinguished Innovator Award

26 October 2013

Congratulations to Ken Smith for being awarded the Lupus Research Institute Distinguished Innovator Award.

Read more at: How cat dander causes allergy
How cat dander causes allergy

How cat dander causes allergy

29 July 2013

Immune system’s extreme reaction to cat allergen previously poorly understood; study could lead to new treatments for those with cat and dog allergies

Contact us

Cambridge Immunology Network Coordinator

University of Cambridge Department of Medicine,
Jeffrey Cheah Biomedical Centre,
Cambridge Biomedical Campus, Puddicombe Way,
Cambridge, CB2 0AW

Contact: webmaster@immunology.cam.ac.uk

Site Privacy & Cookie Policies

 Follow us on Twitter

Watch our webinars

Sign up to our newsletter

We are a FOCIS centre of Excellence

FCEs provide interdisciplinary training programmes for students, fellows and continuing education physicians through FOCIS assisted opportunities

Read more

Study at Cambridge

About the University

Research at Cambridge